United States · 
What does Mission BioCapital invest in?
Mission BioCapital invests most often at Venture and Series B (49% of the rounds on record), in sectors such as Lifesciences, Medicines and Therapeutic.
Mission BioCapital highlights
- 01
13 cheques in the last 12 months
- 02
Mostly Venture and Series B: 49% of its rounds
- 03
Sole investor in 8 rounds, median $4.7M
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- LifesciencesMedicinesTherapeutic
- Based in
- Cambridge, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first52 appearances
- 2026
12 rounds
- Sept
- Sept
- Aug
- Jul
- Apr
- Apr
- Mar
- Feb
- Jan
- Jan
- Jan
- Jan
- 2025
9 rounds
- Nov
- Oct
- Aug
- Apr
- Apr
- Apr
- Mar
- Feb
- Jan
- 2024
12 rounds
- Dec
- Dec
- Dec
- Nov
- Oct
- Oct
- Sept
- Sept
- Jul
- May
- Mar
- Jan
- 2023
3 rounds
- Jun
- Mar
- Mar
- 2022
2 rounds
- Oct
- Feb
- 2021
7 rounds
- Oct
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration8 named
CTChristopher Taylor CarlinChief Compliance Officer and COO of Bioinnovation Management LLCiForm ADV
DKDouglas Kingsley CrawfordGeneral Partner, and Director of Bioinnovation Management LLCiForm ADV
EWEric W. LinsleyManaging General Partner and Director, and Series B Member of Bioinnovation Management LLCiForm ADV
JFJohannes FruehaufGeneral Partner and Director and Series B Member of Bioinnovation Management LLCiForm ADV
LMLoretta McclaryChief Financial Officer, Bioinnovation Management LLCiForm ADV
PDPeter D. ParkerManaging General Partner, CEO, and Series a and B Member of Bioinnovation Management LLCiForm ADV
SWSteven Webb TregayGeneral Partner and Director of Bioinnovation Management LLCiForm ADV
SHSusie HarborthSenior Advisor, Director and Series B Member of Bioinnovation Management LLCiForm ADV
We also hold 17 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$620Mgross assets of its funds, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Mission Biocapital Management Company LLC
- SEC number
- CRD 283710
What they claim to have backed
From their own portfolio page (on their website)
36 of 51 we have independently watched raise
AI ProteinsAlectorAlessatherapeuticsApplaudmedicalAsherbioAtrecaBioLabsCirclepharmaComettherapeuticsDrenbioEffectorEpibiologicsEpiodyneGlycomineImmunostherapeuticsInvenio-imagingKitLabCentralLogicinkMammothMarch BiosciencesNobellfoodsNuvigtherapeuticsPhotoswitchbiosciencesProgentos TherapeuticsQuralisSensorium TherapeuticsSiteonetherapeuticsSoundSymbiomeSymicTangiblescienceVaxessVivacetherapeuticsWildtypefoodsZymergenArasetherapeuticsAvexegenCalitheraCariboubioCavalry BiosciencesCookieYesEikonizoFluxionbioJupiterMBC BioLabsMagnapsleepapneaMykaPrincipiabioVederebioZephyrusbio
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.